These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 26117623

  • 1. Serial Optical Coherence Tomography Evaluation at 6, 12, and 24 Months After Biolimus A9-Eluting Biodegradable Polymer-Coated Stent Implantation.
    Konishi A, Shinke T, Otake H, Takaya T, Osue T, Kinutani H, Kuroda M, Takahashi H, Terashita D, Shite J, Hirata K.
    Can J Cardiol; 2015 Aug; 31(8):980-8. PubMed ID: 26117623
    [Abstract] [Full Text] [Related]

  • 2. Optical coherence tomography analysis of strut coverage in biolimus- and sirolimus-eluting stents: 3-month and 12-month serial follow-up.
    Kim BK, Hong MK, Shin DH, Kim JS, Ko YG, Choi D, Jang Y.
    Int J Cardiol; 2013 Oct 12; 168(5):4617-23. PubMed ID: 23932862
    [Abstract] [Full Text] [Related]

  • 3. Favorable vessel healing after nobori biolimus A9-eluting stent implantation-6- and 12-month follow-up by optical coherence tomography.
    Konishi A, Shinke T, Otake H, Takaya T, Nakagawa M, Inoue T, Hariki H, Osue T, Taniguchi Y, Iwasaki M, Nishio R, Hiranuma N, Kinutani H, Kuroda M, Takahashi H, Terashita D, Shite J, Hirata K.
    Circ J; 2014 Oct 12; 78(8):1882-90. PubMed ID: 24909891
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W.
    JACC Cardiovasc Interv; 2013 Oct 12; 6(10):1026-34. PubMed ID: 24055443
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differences in Vessel Healing Between Sirolimus- and Everolimus-Eluting Stent Implantation for Bifurcation Lesions: The J-REVERSE Optical Coherence Tomography Substudy.
    Terashita D, Otake H, Shinke T, Murasato Y, Kinoshita Y, Yamawaki M, Takeda Y, Fujii K, Yamada S, Shimada Y, Yamashita T, Yumoto K, Hirata K.
    Can J Cardiol; 2016 Mar 12; 32(3):384-90. PubMed ID: 26481078
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An optical coherence tomography study of neointimal morphology and strut coverage at different time intervals from implantation of biodegradable polymer-coated sirolimus-eluting stents.
    Legutko J, Gil RJ, Buszman PE, Kaluza GL, Mintz GS, Roleder T, Krol M, Wojdyla R, Pawlowski T, Brzezinski M, Kondys M, Skwarna B, Jakala J, Zasada W, Partyka L, Dudek D.
    Catheter Cardiovasc Interv; 2018 Aug 01; 92(2):302-309. PubMed ID: 29027737
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y, Attizzani GF, Bezerra HG, Wang W, Tahara S, Yamamoto H, Chamie D, Kanaya T, Mehanna E, Takagi K, Nakamura S, Costa MA.
    JACC Cardiovasc Interv; 2013 Oct 01; 6(10):1035-45. PubMed ID: 24156964
    [Abstract] [Full Text] [Related]

  • 13. Histological validation of frequency domain optical coherence tomography for the evaluation of neointimal formation after a novel polymer-free sirolimus-eluting stent implantation.
    Fu Q, Hu H, Chen W, Tan Z, Li L, Wang D, Chen B.
    Int J Clin Exp Pathol; 2015 Oct 01; 8(9):11068-75. PubMed ID: 26617825
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC, Otto S, Gassdorf J, Nitsche K, Janiak F, Scheller B, Goebel B, Jung C, Figulla HR.
    Circ Cardiovasc Interv; 2014 Dec 01; 7(6):760-7. PubMed ID: 25371536
    [Abstract] [Full Text] [Related]

  • 16. Favorable early vessel healing after everolimus-eluting stent implantation: 3-, 6-, and 12-month follow-up of optical coherence tomography.
    Konishi A, Iwasaki M, Shinke T, Otake H, Takaya T, Osue T, Nishio R, Kinutani H, Kuroda M, Takahashi H, Terashita D, Shite J, Hirata KI.
    J Cardiol; 2018 Sep 01; 72(3):193-199. PubMed ID: 29980334
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of neointimal coverage and extra-stent lumen between sirolimus and everolimus-eluting stent using optical coherence tomography.
    Oda T, Okamura T, Yamada J, Miyagi N, Uehara H, Nao T, Tateishi H, Maeda T, Nakamura T, Shiraishi K, Nakashima T, Nishimura S, Miura T, Matsuzaki M, Yano M.
    Heart Vessels; 2016 Apr 01; 31(4):449-56. PubMed ID: 25614415
    [Abstract] [Full Text] [Related]

  • 20. Impact of different stent alloys on human vascular response to everolimus-eluting stent: an optical coherence tomography study: the OCTEVEREST.
    Guagliumi G, Capodanno D, Ikejima H, Bezerra HG, Sirbu V, Musumeci G, Fiocca L, Lortkipanidze N, Vassileva A, Tahara S, Valsecchi O, Costa MA.
    Catheter Cardiovasc Interv; 2013 Feb 01; 81(3):510-8. PubMed ID: 22431208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.